<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02906566</url>
  </required_header>
  <id_info>
    <org_study_id>33762</org_study_id>
    <nct_id>NCT02906566</nct_id>
  </id_info>
  <brief_title>Retinol on Human Skin Aging in East Asian Descent</brief_title>
  <official_title>Discovery of Effects of Retinol on Human Skin Aging in Individuals of East Asian Descent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There has been increasing evidence for different rates of natural aging in humans and one of
      the best organs to study human aging is skin. Studies have demonstrated anti-aging effects of
      topical agents (such as creams, gels, lotions, or ointments) and one of them, retinol or
      vitamin A, was shown to decrease fine wrinkling in skin of older individuals. Additionally,
      studies of retinol in humans have largely occurred in white populations and so this study
      aims to focus on skin aging in individuals of East Asian descent as they represent a majority
      of the world population. This study aims to better characterize the molecular basis of
      rejuvenation effects and to potentially discover new topical agents with similar and/or more
      effective preservation of skin youthfulness.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">March 9, 2018</completion_date>
  <primary_completion_date type="Actual">March 9, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Genes Upregulated or Downregulated as Assessed by RNA Sequencing (Older Group, Retinol Versus Placebo)</measure>
    <time_frame>Week 12</time_frame>
    <description>Differences in transcript levels are reported as the number that were upregulated or downregulated in the participant's retinol-treated arm versus their placebo-treated arm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Genes Upregulated or Downregulated as Assessed by RNA Sequencing (Younger Group Versus Older Group as Baseline)</measure>
    <time_frame>Week 1</time_frame>
    <description>Differences in transcript levels are reported as the number of genes that were upregulated or downregulated in the Younger Group participant tissue samples, as compared to a baseline provided by tissue samples collected from the Older Group (prior to their treatment).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transepidermal Water Loss</measure>
    <time_frame>Baseline; Week 12</time_frame>
    <description>Transepidermal Water Loss of arm skin was measured in units of grams/hours/meters squared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of Arm Skin Wrinkling</measure>
    <time_frame>Baseline; Week 12</time_frame>
    <description>Wrinkling was assessed by the investigator using a 10-point Likert scale (range 0 to 9, lower scores correspond to less wrinkling).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elasticity on Arm Skin</measure>
    <time_frame>Baseline; week 12</time_frame>
    <description>Elasticity was assessed using cutometry (R2 curve) as millimeters per second</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Participants With Skin and Subcutaneous Adverse Events as a Measure of Type and Severity of Adverse Events</measure>
    <time_frame>Baseline through week 12</time_frame>
    <description>Skin and subcutaneous adverse events were assessed for this outcome and documented and scored according to CTCAE version 4.03.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Intrinsic Aging of Skin</condition>
  <arm_group>
    <arm_group_label>Older Group Ages 55-75</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Active and Placebo. Participants received retinol lotion on one arm and placebo to match on the other arm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Young Group Ages 18-25</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in the group will give tissue sample only for comparison.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Retinol</intervention_name>
    <description>Retinol in the form of vitamin A lotion</description>
    <arm_group_label>Older Group Ages 55-75</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo of Retinol</description>
    <arm_group_label>Older Group Ages 55-75</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  able to provide written informed consent

          -  older group: age between 50 and 75 years

          -  young group: age 18 to 25 years

          -  all four grandparents of Han Chinese, Japanese, Korean descent

          -  body mass index within normal or overweight range

          -  no history of weight loss of &gt;20 lbs within past 5 years

        Exclusion Criteria:

          -  skin condition in the areas of skin biopsy that would obscure results of analysis

          -  topical creams or treatment to arms 2 weeks prior to study baseline visit

          -  individuals with known hypersensitivity to retinoid class of agents (older group only)

          -  prior anti-aging treatments to arms including retinol, microdermabrasion within 2
             weeks of baseline visit

          -  prior laser therapy or surgical procedure to arms

          -  prior radiation or other trauma (extensive burns or abrasions) to arm skin

          -  hormone-based therapy within 4 weeks of enrollment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stanford Dermatology</name>
      <address>
        <city>Redwood City</city>
        <state>California</state>
        <zip>94603</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 26, 2016</study_first_submitted>
  <study_first_submitted_qc>September 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2016</study_first_posted>
  <results_first_submitted>February 27, 2019</results_first_submitted>
  <results_first_submitted_qc>March 25, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 16, 2019</results_first_posted>
  <last_update_submitted>March 25, 2019</last_update_submitted>
  <last_update_submitted_qc>March 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Anne Chang</investigator_full_name>
    <investigator_title>Associate Professor of Dermatology</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin A</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No current plan to share data.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 12, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/66/NCT02906566/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>110 participants were consented; 34 participants were assigned to a study arm.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Older Group Ages 55-75</title>
          <description>Participants received retinol lotion on one arm and placebo to match on the other arm.</description>
        </group>
        <group group_id="P2">
          <title>Young Group Ages 18-25</title>
          <description>Participants in the group will give a tissue sample from one arm only for comparison.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants who were assigned to a treatment arm were included in the analysis.</population>
      <group_list>
        <group group_id="B1">
          <title>Older Group Ages 55-75</title>
          <description>Participants received retinol lotion on one arm and placebo to match on the other arm.</description>
        </group>
        <group group_id="B2">
          <title>Young Group Ages 18-25</title>
          <description>Participants in the group will give a tissue sample from one arm only for comparison.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66" spread="4.7"/>
                    <measurement group_id="B2" value="21.7" spread="3.1"/>
                    <measurement group_id="B3" value="51.7" spread="21.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Genes Upregulated or Downregulated as Assessed by RNA Sequencing (Older Group, Retinol Versus Placebo)</title>
        <description>Differences in transcript levels are reported as the number that were upregulated or downregulated in the participant's retinol-treated arm versus their placebo-treated arm.</description>
        <time_frame>Week 12</time_frame>
        <population>Participants in the &quot;Young Group Ages 18-25&quot; attended a single study visit at week 1 to provide tissue samples for comparison purposes, and are not included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Older Group Ages 55-75</title>
            <description>Participants received retinol lotion on one arm and placebo to match on the other arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Genes Upregulated or Downregulated as Assessed by RNA Sequencing (Older Group, Retinol Versus Placebo)</title>
          <description>Differences in transcript levels are reported as the number that were upregulated or downregulated in the participant's retinol-treated arm versus their placebo-treated arm.</description>
          <population>Participants in the &quot;Young Group Ages 18-25&quot; attended a single study visit at week 1 to provide tissue samples for comparison purposes, and are not included in this analysis.</population>
          <units>genes</units>
          <param>Number</param>
          <units_analyzed>genes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>genes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56615"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Upregulated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Downregulated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Transepidermal Water Loss</title>
        <description>Transepidermal Water Loss of arm skin was measured in units of grams/hours/meters squared.</description>
        <time_frame>Baseline; Week 12</time_frame>
        <population>Participants in the &quot;Young Group Ages 18-25&quot; attended a single study visit at week 1 to provide tissue samples for comparison purposes, and are not included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Retinol Treated Arm</title>
            <description>Participants in the older group (ages 55-75), retinol arm.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Treated Arm</title>
            <description>Participants in the older group (ages 55-75), placebo arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Transepidermal Water Loss</title>
          <description>Transepidermal Water Loss of arm skin was measured in units of grams/hours/meters squared.</description>
          <population>Participants in the &quot;Young Group Ages 18-25&quot; attended a single study visit at week 1 to provide tissue samples for comparison purposes, and are not included in this analysis.</population>
          <units>g/h/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.1" spread="10.2"/>
                    <measurement group_id="O2" value="16.2" spread="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4" spread="6.7"/>
                    <measurement group_id="O2" value="10.2" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Severity of Arm Skin Wrinkling</title>
        <description>Wrinkling was assessed by the investigator using a 10-point Likert scale (range 0 to 9, lower scores correspond to less wrinkling).</description>
        <time_frame>Baseline; Week 12</time_frame>
        <population>Participants in the &quot;Young Group Ages 18-25&quot; attended a single study visit at week 1 to provide tissue samples for comparison purposes, and are not included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Retinol Treated Arm</title>
            <description>Participants in the older group (ages 55-75), retinol arm.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Treated Arm</title>
            <description>Participants in the older group (ages 55-75), placebo arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Severity of Arm Skin Wrinkling</title>
          <description>Wrinkling was assessed by the investigator using a 10-point Likert scale (range 0 to 9, lower scores correspond to less wrinkling).</description>
          <population>Participants in the &quot;Young Group Ages 18-25&quot; attended a single study visit at week 1 to provide tissue samples for comparison purposes, and are not included in this analysis.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.15" spread="1.96"/>
                    <measurement group_id="O2" value="5.5" spread="1.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.85" spread="1.79"/>
                    <measurement group_id="O2" value="5.175" spread="1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Elasticity on Arm Skin</title>
        <description>Elasticity was assessed using cutometry (R2 curve) as millimeters per second</description>
        <time_frame>Baseline; week 12</time_frame>
        <population>Participants in the &quot;Young Group Ages 18-25&quot; attended a single study visit at week 1 to provide tissue samples for comparison purposes, and are not included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Retinol Treated Arm</title>
            <description>Participants in the older group (ages 55-75), retinol arm.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Treated Arm</title>
            <description>Participants in the older group (ages 55-75), placebo arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Elasticity on Arm Skin</title>
          <description>Elasticity was assessed using cutometry (R2 curve) as millimeters per second</description>
          <population>Participants in the &quot;Young Group Ages 18-25&quot; attended a single study visit at week 1 to provide tissue samples for comparison purposes, and are not included in this analysis.</population>
          <units>millimeters per second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8623" spread="0.0791"/>
                    <measurement group_id="O2" value="0.8753" spread="0.0464"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8587" spread="0.0655"/>
                    <measurement group_id="O2" value="0.8576" spread="0.0684"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Participants With Skin and Subcutaneous Adverse Events as a Measure of Type and Severity of Adverse Events</title>
        <description>Skin and subcutaneous adverse events were assessed for this outcome and documented and scored according to CTCAE version 4.03.</description>
        <time_frame>Baseline through week 12</time_frame>
        <population>Participants in the &quot;Young Group Ages 18-25&quot; attended a single study visit at week 1 to provide tissue samples for comparison purposes, and are not included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Retinol Treated Arm</title>
            <description>Participants in the older group (ages 55-75), retinol arm.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Treated Arm</title>
            <description>Participants in the older group (ages 55-75), placebo arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Participants With Skin and Subcutaneous Adverse Events as a Measure of Type and Severity of Adverse Events</title>
          <description>Skin and subcutaneous adverse events were assessed for this outcome and documented and scored according to CTCAE version 4.03.</description>
          <population>Participants in the &quot;Young Group Ages 18-25&quot; attended a single study visit at week 1 to provide tissue samples for comparison purposes, and are not included in this analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dermatitis (Grade 1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tingling sensation after application (Grade 1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Genes Upregulated or Downregulated as Assessed by RNA Sequencing (Younger Group Versus Older Group as Baseline)</title>
        <description>Differences in transcript levels are reported as the number of genes that were upregulated or downregulated in the Younger Group participant tissue samples, as compared to a baseline provided by tissue samples collected from the Older Group (prior to their treatment).</description>
        <time_frame>Week 1</time_frame>
        <population>Only the participants in &quot;Younger Group (ages 18-25)&quot; are included in the analysis, since a comparison of the baseline data for the &quot;Older Group (ages 55-75)&quot; against itself is not clinically meaningful.</population>
        <group_list>
          <group group_id="O1">
            <title>Young Group Ages 18-25</title>
            <description>Participants in the group will give a tissue sample from one arm only for comparison.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Genes Upregulated or Downregulated as Assessed by RNA Sequencing (Younger Group Versus Older Group as Baseline)</title>
          <description>Differences in transcript levels are reported as the number of genes that were upregulated or downregulated in the Younger Group participant tissue samples, as compared to a baseline provided by tissue samples collected from the Older Group (prior to their treatment).</description>
          <population>Only the participants in &quot;Younger Group (ages 18-25)&quot; are included in the analysis, since a comparison of the baseline data for the &quot;Older Group (ages 55-75)&quot; against itself is not clinically meaningful.</population>
          <units>genes</units>
          <param>Number</param>
          <units_analyzed>genes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>genes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56615"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Downregulated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="775"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Upregulated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="587"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 12 weeks.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Older Group Ages 55-75</title>
          <description>Participants received retinol lotion on one arm and placebo to match on the other arm.</description>
        </group>
        <group group_id="E2">
          <title>Young Group Ages 18-25</title>
          <description>Participants in the group will give a tissue sample from one arm only for comparison.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Upper respiratory infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Anne L. Chang</name_or_title>
      <organization>Stanford University</organization>
      <phone>650-721-7195</phone>
      <email>alschang@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

